Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001457612-22-000020)

Filing Details

Accession Number:: 0001457612-22-000020
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2022-03-16 17:31:08
Reporting Period:: 2021-12-31

Accepted Time:: 2022-03-16 17:31:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1457612	Genocea Biosciences Inc.	GNCA	Biological Products, (No Disgnostic Substances) (2836)	510596811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1696784	Diantha Duvall	C/O Genocea Biosciences, Inc. 100 Acorn Park Drive, 5Th Floor Cambridge MA 02140	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-04-02	925	$2.71	62,997	No	4	S	Direct
Common Stock	Disposition	2021-06-01	511	$2.23	62,486	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.